Gene · 5518
Papers1,733
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,733
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Histopathological and Immunohistochemical Prognostic Factors in High-Grade Non-Endometrioid Carcinomas of the Endometrium (HG-NECs): Is It Possible to Identify Subgroups at Increased Risk? | Diagnostics (Basel) | 2023 | 37443564 | PubTator, text mining | PubMed |
| Platelet-derived microparticles provoke chronic lymphocytic leukemia malignancy through metabolic reprogramming. | Front Immunol | 2023 | 37441073 | PubTator, text mining | PubMed |
| The Role of FBXW7 in Gynecologic Malignancies. | Cells | 2023 | 37408248 | PubTator, text mining | PubMed |
| Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity. | Cell Rep Med | 2023 | 37390828 | PubTator, text mining | PubMed |
| Imaging single CaMKII holoenzymes at work by high-speed atomic force microscopy. | Sci Adv | 2023 | 37390213 | PubTator, text mining | PubMed |
| Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas. | Cancer Res Commun | 2023 | 37377900 | PubTator, text mining | PubMed |
| Quantum-based modeling implies that bidentate Arg89-substrate binding enhances serine/threonine protein phosphatase-2A(PPP2R5D/PPP2R1A/PPP2CA)-mediated dephosphorylation. | Front Cell Dev Biol | 2023 | 37377738 | PubTator, text mining | PubMed |
| Identification of Somatic Mutations in Plasma Cell-Free DNA from Patients with Metastatic Oral Squamous Cell Carcinoma. | Int J Mol Sci | 2023 | 37373553 | PubTator, text mining | PubMed |
| Uncharacterized Proteins CxORFx: Subinteractome Analysis and Prognostic Significance in Cancers. | Int J Mol Sci | 2023 | 37373333 | PubTator, text mining | PubMed |
| Clinical Challenges in the Management of Malignant Ovarian Germ Cell Tumours. | Int J Environ Res Public Health | 2023 | 37372675 | PubTator, text mining | PubMed |
| Gastric Cancer Vascularization and the Contribution of Reactive Oxygen Species. | Biomolecules | 2023 | 37371466 | PubTator, text mining | PubMed |
| Tumor-Infiltrating CD8-Positive T-Cells Associated with MMR and p53 Protein Expression Can Stratify Endometrial Carcinoma for Prognosis. | Diagnostics (Basel) | 2023 | 37370880 | PubTator, text mining | PubMed |
| Large, Nested Variant of Urothelial Carcinoma Is Enriched with Activating Mutations in Fibroblast Growth Factor Receptor-3 among Other Targetable Mutations. | Cancers (Basel) | 2023 | 37370778 | PubTator, text mining | PubMed |
| Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network. | J Transl Med | 2023 | 37353806 | PubTator, text mining | PubMed |
| Re-Shaping the Pancreatic Cancer Tumor Microenvironment: A New Role for the Metastasis Suppressor NDRG1. | Cancers (Basel) | 2023 | 37345116 | PubTator, text mining | PubMed |
| Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment. | Cancers (Basel) | 2023 | 37345024 | PubTator, text mining | PubMed |
| Clinical features of PPP2 syndrome type R5D (Jordan's syndrome) to support standardization of care. | Cold Spring Harb Mol Case Stud | 2023 | 37339871 | PubTator, text mining | PubMed |
| Structural insights into regulation of the PEAK3 pseudokinase scaffold by 14-3-3. | Nat Commun | 2023 | 37336883 | PubTator, text mining | PubMed |
| Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy. | Gynecol Oncol Rep | 2023 | 37325296 | PubTator, text mining | PubMed |
| PPP2R1A regulates migration persistence through the NHSL1-containing WAVE Shell Complex. | Nat Commun | 2023 | 37322026 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5518/papers?page=8